Literature DB >> 1409173

Magnesium deficiency and diabetes mellitus. Causes and effects.

R K Rude1.   

Abstract

A large body of evidence demonstrates the prevalence and adverse clinical consequences of magnesium deficiency in patients with diabetes mellitus. It would be prudent for physicians who treat these patients to consider magnesium deficiency as a contributing factor in many diabetic complications and in exacerbation of the disease itself. Repletion of the deficiency or prophylactic supplementation with oral magnesium may help avoid or ameliorate such complications as arrhythmias, hypertension, and sudden cardiac death and may even improve the course of the diabetic condition.

Entities:  

Mesh:

Year:  1992        PMID: 1409173     DOI: 10.1080/00325481.1992.11701494

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  11 in total

1.  Hypomagnesaemia in IDDM patients with microalbuminuria and clinical proteinuria.

Authors:  J C Pickup; G D Chusney; M A Crook; G C Viberti
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

2.  Thiazide therapy for diabetes.

Authors:  W D Panton
Journal:  CMAJ       Date:  1994-06-01       Impact factor: 8.262

3.  Desalinated underground seawater of Jeju Island (Korea) improves lipid metabolism in mice fed diets containing high fat and increases antioxidant potential in t-BHP treated HepG2 cells.

Authors:  Jung-Ran Noh; Gil-Tae Gang; Yong-Hoon Kim; Keum-Jin Yang; Chul-Ho Lee; O-Su Na; Gi-Ju Kim; Won-Keun Oh; Young-Don Lee
Journal:  Nutr Res Pract       Date:  2010-02-24       Impact factor: 1.926

4.  Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease.

Authors:  Yusuke Sakaguchi; Tatsuya Shoji; Terumasa Hayashi; Akira Suzuki; Morihiro Shimizu; Kensuke Mitsumoto; Hiroaki Kawabata; Kakuya Niihata; Noriyuki Okada; Yoshitaka Isaka; Hiromi Rakugi; Yoshiharu Tsubakihara
Journal:  Diabetes Care       Date:  2012-04-12       Impact factor: 19.112

5.  Prevalence of Hypomagnesaemia among Obese Type 2 Diabetic Patients Attending the National Center for Diabetes, Endocrinology and Genetics (NCDEG).

Authors:  Dana Hyassat; Ebtihaj Al Sitri; Anwar Batieha; Mohammed El-Khateeb; Kamel Ajlouni
Journal:  Int J Endocrinol Metab       Date:  2014-07-01

6.  Status of serum magnesium in Egyptian children with type 1 diabetes and its correlation to glycemic control and lipid profile.

Authors:  Doaa Shahbah; Amr Abo El Naga; Tamer Hassan; Marwa Zakaria; Mohamed Beshir; Salah Al Morshedy; Mohamed Abdalhady; Ezzat Kamel; Doaa Abdel Rahman; Lamiaa Kamel; May Abdelkader
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

7.  Oral magnesium supplementation improves glycemic control and lipid profile in children with type 1 diabetes and hypomagnesaemia.

Authors:  Doaaa Shahbah; Tamer Hassan; Saeed Morsy; Hosam El Saadany; Manar Fathy; Ashgan Al-Ghobashy; Nahla Elsamad; Ahmed Emam; Ahmed Elhewala; Boshra Ibrahim; Sherief El Gebaly; Hany El Sayed; Hanan Ahmed
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

8.  Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation.

Authors:  Nadia Zghoul; Nada Alam-Eldin; Ivan Tong Mak; Burton Silver; William B Weglicki
Journal:  Diabetes Metab Syndr Obes       Date:  2018-08-02       Impact factor: 3.168

9.  Association between magnesium concentrations and prediabetes: a systematic review and meta-analysis.

Authors:  Sara Ebrahimi Mousavi; Seyed Mojtaba Ghoreishy; Amirhossein Hemmati; Hamed Mohammadi
Journal:  Sci Rep       Date:  2021-12-22       Impact factor: 4.379

10.  Evidence of impaired bone quality in men with type 1 diabetes: a cross-sectional study.

Authors:  Unni Syversen; Mats Peder Mosti; Ida Maria Mynarek; Trude Seselie Jahr Vedal; Kristin Aasarød; Trude Basso; Janne E Reseland; Per Medbøe Thorsby; Bjorn O Asvold; Erik Fink Eriksen; Astrid Kamilla Stunes
Journal:  Endocr Connect       Date:  2021-08-13       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.